About Regenimo Biosciences
Regenimo Biosciences is a private company based in Houston, Texas, incorporated in 2025 in Delaware. It has reported $2,000,000 raised in one offering on Form D since November 2025. Its chief executive is Sharon Shacham.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 2025 | Nov 25, 2025 | $2,000,000fully sold | 6 | $333K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Regenimo Biosciences's Form D filed Nov 25, 2025.